Mazdutide
IBI362 / LY3305677
- Molecular form
- Oxyntomodulin-related analog
Oxyntomodulin-related analog
Open the sources to check how the studies were done and what they can support.
A dual GLP-1 and glucagon receptor agonist with published phase 3 weight-management evidence from Chinese adults.
- Family
- Dual metabolic receptor agonist
- Research target
- GLP-1 and glucagon receptors
- Molecular form
- Oxyntomodulin-related analog
What to know about the research
The GLORY-1 population, comparator and follow-up define what the trial supports. Approval status is jurisdiction-specific and should be checked separately.
Check the exact compound
Keep mazdutide distinct from survodutide despite their shared receptor pair.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries